Evidence map›Paper›PMID 21801351›Full record

ArticleJournal of the International AIDS Society2011

Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study.

Livio Azzoni, Andrea S Foulkes, Cynthia Firnhaber, Xiangfan Yin, Nigel J Crowther, Deborah Glencross, Denise Lawrie, Wendy Stevens, Emmanouil Papasavvas, Ian Sanne and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00100646 (A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00100646 nacompletednot on this map

A Randomized Clinical Trial Assessing Continuous HAART Versus Interrupted HAART in a Resource Poor Clinic

TypeinterventionalSponsorThe Wistar InstituteRan2007 to 2010Enrolled30ConditionsHIV InfectionsArmsStructured treatment interruption, Lamivudine, Lopinavir/Ritonavir, Stavudine, Rabies de novo antigen
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Livio Azzoni *HIV-1 Immunopathogenesis Laboratory, the Wistar Institute, Philadelphia, PA, USA.
Andrea S Foulkes *School of Public Health and Health Sciences, University of Massachusetts, Amherst, USA.
Cynthia FirnhaberClinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Xiangfan YinHIV-1 Immunopathogenesis Laboratory, the Wistar Institute, Philadelphia, PA, USA.
Nigel J CrowtherDepartment of Chemical Pathology, National Health Laboratory Service and University of the Witwatersrand, Johannesburg, South Africa.
Deborah GlencrossDepartment of Hematology and Molecular Medicine, National Health Laboratory Service and University of the Witwatersrand, Johannesburg, South Africa.
Denise LawrieDepartment of Hematology and Molecular Medicine, National Health Laboratory Service and University of the Witwatersrand, Johannesburg, South Africa.
Wendy StevensDepartment of Hematology and Molecular Medicine, National Health Laboratory Service and University of the Witwatersrand, Johannesburg, South Africa.
Emmanouil PapasavvasHIV-1 Immunopathogenesis Laboratory, the Wistar Institute, Philadelphia, PA, USA.
Ian SanneClinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Luis J MontanerHIV-1 Immunopathogenesis Laboratory, the Wistar Institute, Philadelphia, PA, USA.

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
HIV Therapy &Interruption RCT in Resource Poor ClinicU01AI051986 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J · 2005 to 2010
$3.0M
Methods for high-dimensional data in HIV/CVD researchR01HL107196 · NHLBI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FOULKES, ANDREA S · 2011 to 2015
$2.0M
Methods for high-dimensional data in HIV researchR01AI056983 · NIAID · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FOULKES, ANDREA S · 2005 to 2009
$1.5M
TB-related Immune Reconstitution Syndrome in HIV-1 Infected South AfricansR01AI069996 · NIAID · WISTAR INSTITUTE · PI AZZONI, LIVIO · 2006 to 2009
$1.3M
NCI NIH HHS (P30 CA10815NHLBI NIH HHS R01 HL107196NIAID NIH HHS R01 AI056983NIAID NIH HHS R01 AI069996NIAID NIH HHS UO1AI51986
6 · The paper itself

Abstract

backgroundThe degree of immune reconstitution achieved in response to suppressive ART is associated with baseline individual characteristics, such as pre-treatment CD4 count, levels of viral replication, cellular activation, choice of treatment regimen and gender. However, the combined effect of these variables on long-term CD4 recovery remains elusive, and no single variable predicts treatment response. We sought to determine if adiposity and molecules associated with lipid metabolism may affect the response to ART and the degree of subsequent immune reconstitution, and to assess their ability to predict CD4 recovery.

methodsWe studied a cohort of 69 (48 females and 21 males) HIV-infected, treatment-naïve South African subjects initiating antiretroviral treatment (d4T, 3Tc and lopinavir/ritonavir). We collected information at baseline and six months after viral suppression, assessing anthropometric parameters, dual energy X-ray absorptiometry and magnetic resonance imaging scans, serum-based clinical laboratory tests and whole blood-based flow cytometry, and determined their role in predicting the increase in CD4 count in response to ART.

resultsWe present evidence that baseline CD4+ T cell count, viral load, CD8+ T cell activation (CD95 expression) and metabolic and anthropometric parameters linked to adiposity (LDL/HDL cholesterol ratio and waist/hip ratio) significantly contribute to variability in the extent of CD4 reconstitution (ΔCD4) after six months of continuous ART.

conclusionsOur final model accounts for 44% of the variability in CD4+ T cell recovery in virally suppressed individuals, representing a workable predictive model of immune reconstitution.

Indexed as

Lipid MetabolismAbsorptiometry, PhotonAdiposityAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountCD4-Positive T-LymphocytesCohort StudiesFemaleFlow CytometryHIV-1HIV InfectionsHumansMagnetic Resonance ImagingMaleAnti-HIV Agents

Identifiers

PMID21801351
PMCPMC3163506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.